Celebrating Diversity Within the Sickle Cell Community: Commitment, Innovation, Practice
avatar for Leila Jerome Clay, MD, MCTS

Leila Jerome Clay, MD, MCTS

Johns Hopkins ALL Children's Hospital
Dr. Clay is the Director of the Sickle Cell Disease Program at John Hopkins All Children’s Hospital and Assistant Professor of Pediatrics, Section of Hematology at Johns Hopkins University School of Medicine
Dr. Clay received her Bachelor’s degree in Physical Anthropology from New York University. She later earned her Medical Doctorate from Morehouse School of Medicine in Atlanta, GA (2006).  She completed her Internal Medicine and Pediatrics residency at Rutgers / New Jersey Medical School (2010). She finished her Pediatric Hematology/Oncology fellowship at University of North Carolina Hospitals, Chapel Hill, NC (2013) with a focus in Sickle Cell Disease. Dr. Clay obtained a Master’s in Clinical and Translational Science at Augusta University in 2016.

Dr. Clay was previously at Augusta University where she treated children, adolescents and young adults with rare blood disorders such as sickle cell disease. She was the director of Sickle Cell Disease Transition at Augusta University Sickle Cell Center and played the role of a physician navigator in transitioning adolescent care to adult care. During her time at Augusta University, under the grant support of HRSA and the DPH, she established a Sickle Cell transition program. Dr. Clay recently joined John Hopkins All Children’s Hospital as the Sickle Cell Program director. She is currently a site PI for the HRSA EMBRACE project and a site PI for the PCORI ST3P-Up project.

Dr. Clay has established her research in sickle cell disease where she studied the mechanistic contribution of vitamin D deficiency and its effects of disease manifestation of sickle cell disease as well as bone disease. Her primary professional objective is to translate her clinical research to the field. She remains focus in improving the care of the adult and young adult population in regards to Sickle Cell Disease.

My Speakers Sessions

Thursday, October 11

2:15pm EDT